Detailed price information for Alnylam Pharmaceuticals (ALNY-Q) from The Globe and Mail including charting and trades.
BOSTON--(BUSINESS WIRE)--Ancora Heart, Inc., a company developing a completely transcatheter device-based therapy to address heart failure (HF), today announced that patients treated with the ...
New insights into the structure of muscle tissue in the heart have been provided in a study led by researchers from McGill University. This is a finding that promises to contribute to the study of ...
Announcing a new article publication for Cardiovascular Innovations and Applications journal. The heart is the central organ of the human circulatory system. Both congenital and acquired structural ...
BAG3 DCM is a devastating monogenic heart disease affecting more than 70,000 patients in the U.S., Europe, and U.K., with almost 25% of patients requiring a heart transplant AFTX-201 is a potential ...
According to the American College of Cardiology, nearly 6.7 million Americans have heart failure, more than half with preserved ejection fraction. This condition often leads to frequent ...